SAB Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov '24 Nov 7, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	31	63	30	340	-	-
Market Cap Growth	-24.40%	113.36%	-91.24%	-	-	-
Enterprise Value	11	66	27	336	-	-
Last Close Price	3.95	6.88	5.90	78.10	-	-
PE Ratio	-	-0.90	-1.37	-12.40	-	-
PS Ratio	22.53	28.33	1.24	5.58	-	-
PB Ratio	0.99	1.11	0.96	8.81	-	-
P/FCF Ratio	-0.65	-2.51	-1.16	-37.91	-	-
P/OCF Ratio	-0.65	-2.52	-1.27	170.89	-	-
EV/Sales Ratio	6.99	29.32	1.14	5.51	-	-
EV/EBITDA Ratio	0.15	-1.91	-1.06	-28.19	-	-
EV/EBIT Ratio	0.14	-1.72	-0.94	-25.06	-	-
EV/FCF Ratio	0.18	-2.59	-1.06	-37.47	-	-
Debt / Equity Ratio	0.12	0.10	0.19	0.22	0.21	0.99
Debt / EBITDA Ratio	-	-	-	-	0.38	-
Debt / FCF Ratio	-0.12	-0.23	-0.23	-0.95	-2.98	-0.78
Asset Turnover	0.04	0.03	0.36	0.88	1.48	-
Quick Ratio	3.46	5.23	1.37	1.56	3.00	1.98
Current Ratio	3.69	5.45	1.47	1.90	3.11	2.01
Return on Equity (ROE)	-174.73%	-95.51%	-53.85%	-44.21%	86.15%	-
Return on Assets (ROA)	-78.80%	-35.30%	-27.37%	-12.16%	34.47%	-
Return on Capital (ROIC)	-105.52%	-47.50%	-43.01%	-17.77%	41.14%	-
Earnings Yield	-139.47%	-66.52%	-63.04%	-5.05%	-	-
FCF Yield	-118.01%	-39.91%	-86.20%	-2.64%	-	-
Buyback Yield / Dilution	-74.13%	-26.86%	-59.20%	-1.21%	23.30%	-
Total Shareholder Return	-74.13%	-26.86%	-59.20%	-1.21%	23.30%	-

Source: S&P Capital IQ. Standard template. Financial Sources.